Sep 16, 2020 6:55 am EDT Acasti Appoints Seasoned Executive Brian D. Ford CPA-CA as Chief Financial Officer
Sep 11, 2020 7:00 am EDT Acasti Announces Filing and Mailing of Information Circular and Change in Record Date
Aug 31, 2020 7:00 am EDT Acasti Pharma Reports Topline Triglyceride Results from Phase 3 TRILOGY 2 Study of CaPre in Patients with Severe Hypertriglyceridemia
Jul 31, 2020 7:55 am EDT Acasti Pharma Submits Statistical Analysis Plan to FDA and Remains On Track to Report TRILOGY 2 Topline Data On or About August 31, 2020
Apr 20, 2020 8:30 am EDT Acasti Pharma Awarded Notice of Allowance for Second Composition of Matter Patent in Canada
Apr 1, 2020 8:30 am EDT Acasti Pharma Submits FDA Meeting Request on Schedule, and FDA Meeting Expected in the Second Half of June